Jorge Bartolome

Jorge Bartolome has a diverse work experience spanning over several companies. Jorge is currently the Chief Executive Officer at AreteiaTx since July 2022. Prior to this role, they worked at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2017 to 2022, where they held positions including President Janssen Canada and Vice President Cardiovascular Sales and Marketing. Before that, they worked at GlaxoSmithKline for a significant period of time, holding various roles such as Senior Vice President, Business Unit Leader and Managing Director for Singapore, Malaysia, and Brunei. Jorge also worked as a Commercial Director, Marketing Director/Manager, and Management Associate during their tenure at GlaxoSmithKline. Additionally, they started their career as a Management Associate at GSK in 1992.

Jorge Bartolome attended Duke University. No specific start or end year is provided, and there is no information regarding their degree or field of study.